跳至主要内容
临床试验/ACTRN12610000476033
ACTRN12610000476033尚未招募2 期

The effect of Acetazolamide on visual acuity, retinal thickness and macular cyst size in patients with X-linked retinoschisis

The University of Sydney0 个研究点目标入组 30 人开始时间: 2010年6月10日最近更新:

试验速览

阶段
2 期
状态
尚未招募
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
o limit 至 o limit(—)
性别
All

入选标准

  • Patients with X-linked retinoschisis diagnosis and stable ocular fixation with no clinically significant media opacities.
  • There will be no age restrictions

排除标准

  • -Hypersensitivity to sulphonamides and sulphonamide derivatives
  • - Women who are pregnant
  • - People in existing dependent or unequal relationships
  • - People highly dependent on medical care
  • - Aboriginal and/or Torres Striait Islander People
  • - People who may be involved in illegal activity
  • - People with an intellectual or mental impairment
  • - People whose primary language is other than English.
  • - A refractive error greater than ±6 diopters (D) sphere
  • - Optic neuropathy
  • - The presence of nystagmus or any other retinal diseases affecting the macula other than retinoschisis
  • - A recent history (<6months) of intraocular surgery, and poor optical coherent tomography (OCT) image quality.

研究者

相似试验

Acetazolamide in X-linked Retinoschisis | 临床试验